The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.
As well as testing the drug as a mono therapy, Dragonfly is also studying DF6002 in combination with PD-1 inhibiting treatment, such as BMS’ Opdivo (nivolumab).
Sales of immunotherapy Opdivo decreased due to COVID-19 impact. Bristol-Myers Squibb has posted better-than-expected results in the second quarter of the year, with shares in the company ... One concerning caveat among the otherwise positive results was
However, Roche is likely to face fierce competition from rival checkpoint inhibitors, namely Merck &Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo which have already been on the market ... Opdivo, on the other hand, was first
number of cancer immunotherapies including Merck &Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab).
Both of those are also under review in Europe. Following after is an FDA review of checkpoint inhibitor combination Opdivo (nivolumab) and Yervoy (ipilimumab) in first-line non-small cell lung
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...